|
Consolidated Basic Cancer Research Program
|
3P30CA010815-47S1
|
$142,498
|
$14,250
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-47
|
$2,645,581
|
$264,558
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Assembly compartment formation and nuclear alterations mediated by HCMV
|
4R01CA157846-05
|
$332,000
|
$332,000
|
ALWINE, JAMES
|
UNIVERSITY OF PENNSYLVANIA
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-42S1
|
$125,000
|
$12,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
4P30CA014520-42
|
$4,288,496
|
$428,850
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
$40,597
|
Barr, Frederic
|
CCR (NCI)
|
|
The Function of EBV LMP1 CTAR3 in Sumoylation and Oncogenesis
|
5R00CA160786-04
|
$246,208
|
$246,208
|
BENTZ, GRETCHEN
|
MERCER UNIVERSITY MACON
|
|
Cancer Center Support Grant
|
3P30CA006516-51S1
|
$122,500
|
$2,450
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S2
|
$37,500
|
$750
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S3
|
$125,000
|
$2,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S4
|
$200,000
|
$4,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S5
|
$60,000
|
$1,200
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S6
|
$199,953
|
$3,999
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S7
|
$500,000
|
$10,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-51S8
|
$750,000
|
$15,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
4P30CA006516-51
|
$11,151,311
|
$223,026
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Experimental Therapeutics and BioMonitoring for Brain Tumors
|
4P01CA069246-19
|
$1,348,678
|
$323,683
|
BREAKEFIELD, XANDRA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
5U54CA190146-03
|
$693,281
|
$318,909
|
CASPER, COREY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Modeling KSHV latency in vivo
|
4R01CA103646-10
|
$328,499
|
$328,499
|
CESARMAN, ETHEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Early events of in vitro KSHV infection
|
4R01CA168472-05
|
$320,588
|
$320,588
|
CHANDRAN, BALA
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
KSHV interactions with host inflammasome components
|
5R01CA180758-03
|
$320,588
|
$320,588
|
CHANDRAN, BALA
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
E2-Cellular Complexes in HPV Chromatin Transcription
|
4R01CA103867-12
|
$395,910
|
$158,364
|
CHIANG, CHENG-MING
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model
|
5R01CA195532-02
|
$377,464
|
$377,464
|
CHIOCCA, E.
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-07S1
|
$200,000
|
$2,000
|
COBB, MELANIE
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-07
|
$2,479,396
|
$24,794
|
COBB, MELANIE
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma
|
5R01CA184283-03
|
$550,450
|
$275,225
|
COBBS, CHARLES
|
SWEDISH MEDICAL CENTER, FIRST HILL
|
|
CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages
|
1R44CA206788-01
|
$232,464
|
$232,464
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
|
4R44CA192859-02
|
$633,492
|
$633,492
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Immune Modulation by Gammaherpesviruses
|
4R01CA168477-05
|
$234,200
|
$234,200
|
COSCOY, LAURENT
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients
|
1R01CA206019-01
|
$735,600
|
$183,900
|
COZEN, WENDY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Viral Oncology Training Grant
|
5T32CA009111-38
|
$378,220
|
$113,466
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-08S1
|
$59,999
|
$1,200
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
4P30CA138292-08
|
$2,038,828
|
$40,777
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Herpesviral Oncogenesis, Latency and Reactivation
|
2P01CA019014-37
|
$1,811,800
|
$1,811,800
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Role of KSHV viral proteins in signaling and pathogenesis
|
4R01CA096500-14
|
$281,108
|
$281,108
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-40
|
$7,975,543
|
$398,777
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S1
|
$31,250
|
$1,563
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S2
|
$499,967
|
$24,998
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S3
|
$200,000
|
$10,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Center Support Grant
|
3P30CA047904-28S1
|
$115,192
|
$4,608
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-28S2
|
$60,000
|
$2,400
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-28S3
|
$199,837
|
$7,993
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA047904-28S4
|
$749,690
|
$29,988
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
5P30CA047904-28
|
$5,129,654
|
$205,186
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Control of CMV infection post-HCT using attenuated MVA-based CMV subunit vaccine
|
4R01CA077544-15
|
$539,228
|
$539,228
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Molecular Basis of Cancer Virus Replication, Transformation, and Innate Defense
|
3P01CA016038-42S1
|
$106,835
|
$59,828
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
|
Molecular Basis of Cancer Virus Replication, Transformation, and Innate Defense
|
5P01CA016038-42
|
$980,728
|
$549,208
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
|
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
|
2R01CA163217-06
|
$342,759
|
$171,380
|
DITTMER, DIRK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
5P30CA016042-41
|
$4,295,192
|
$386,567
|
DORSHKIND, KENNETH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-18S3
|
$1,479,340
|
$133,141
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
Total relevant funding to Herpes - Other for this search: $47,283,259
|